Case T-154/03: Judgment of the Court of First Instance of 17 November 2005 — Biofarma v OHIM (Community trade mark — Opposition proceedings — Earlier national word marks ARTEX — Application for Community word mark ALREX — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 40/94) 
Judgment of the Court of First Instance of 17 November 2005 — Biofarma v OHIM 
(Case T-154/03) [1] 
Parties 
Applicant(s): Biofarma SA (Neuilly-sur-Seine, France) (represented by V. Gil Vega, A. Ruiz López and D. Gonzalez Maroto, lawyers) 
Defendant(s): Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by W. Verburg and A. Folliard-Monguiral, Agents) 
Other party or parties to the proceedings before the Board of Appeal of OHIM intervening before the Court of First Instance: Bausch %amp% Lomb Pharmaceuticals, Inc. (Tampa, Florida, United States) (represented by S. Klos, lawyer) 
Action 
brought against the decision of the Third Board of Appeal of OHIM of 5 February 2003 (Case R 370/2002 3), concerning opposition proceedings between Biofarma SA and Bausch %amp% Lomb Pharmaceuticals, Inc. 
Operative part of the judgment 
The Court: 
1. Annuls the decision of the Third Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 5 February 2003 (Case R 370/2002-3); 
2. Orders OHIM to bear its own costs and to pay those incurred by the applicant; 
3. Orders the intervener to bear its own costs. 
[1] OJ C 158, 5.7.2003. 
-------------------------------------------------- 
